WO2006003222A9 - Uso del formoterol en el tratamiento profiláctico y/o terapéutico del desgaste muscular y/o síndrome caquéctico, asociados a estados catabólicos de ciertas enfermedades como cáncer, sida, infecciones, diabetes y otras - Google Patents
Uso del formoterol en el tratamiento profiláctico y/o terapéutico del desgaste muscular y/o síndrome caquéctico, asociados a estados catabólicos de ciertas enfermedades como cáncer, sida, infecciones, diabetes y otras Download PDFInfo
- Publication number
- WO2006003222A9 WO2006003222A9 PCT/ES2005/000365 ES2005000365W WO2006003222A9 WO 2006003222 A9 WO2006003222 A9 WO 2006003222A9 ES 2005000365 W ES2005000365 W ES 2005000365W WO 2006003222 A9 WO2006003222 A9 WO 2006003222A9
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formoterol
- prophylactic
- infections
- diabetes
- aids
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- AIDS & HIV (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05763090A EP1818052B1 (en) | 2004-06-29 | 2005-06-28 | Use of formoterol in the prophylactic and/or therapeutic treatment of muscle wasting and/or cachectic syndrome which are associated with catabolic conditions of certain diseases, such as cancer, aids, infections, diabetes and others |
DK05763090.7T DK1818052T3 (da) | 2004-06-29 | 2005-06-28 | Anvendelse af formoterol i den profylaktiske og/eller terapeutiske behandling af muskelsvind og/eller kakektisk syndrom i forbindelse med kataboliske forhold af visse sygdomme såsom cancer, aids, infektioner, diabetes og andre |
DE602005017659T DE602005017659D1 (de) | 2004-06-29 | 2005-06-28 | Verwendung von formoterol in der prophylaktischen und/oder therapeutischen behandlung von muskelschwund und/oder kachexie-syndrom im zusammenhang mit katabolischen zuständen bei bestimmten krankheiten, wie z.b. krebs, aids, infektionen, diabetes und andere |
PL05763090T PL1818052T3 (pl) | 2004-06-29 | 2005-06-28 | Zastosowanie formoterolu w profilaktycznym i/lub terapeutycznym leczeniu wyniszczenia mięśniowego i/lub zespołu wyniszczenia, związanych ze stanami katabolicznymi w przebiegu niektórych chorób, takich jak nowotwory, AIDS, zakażenia, cukrzyca i inne |
AT05763090T ATE447944T1 (de) | 2004-06-29 | 2005-06-28 | Verwendung von formoterol in der prophylaktischen und/oder therapeutischen behandlung von muskelschwund und/oder kachexie-syndrom im zusammenhang mit katabolischen zuständen bei bestimmten krankheiten, wie z.b. krebs, aids, infektionen, diabetes und andere |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200401941A ES2245612B1 (es) | 2004-06-29 | 2004-06-29 | Nuevo uso terapeutico del formoterol. |
ESP200401941 | 2004-06-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006003222A1 WO2006003222A1 (es) | 2006-01-12 |
WO2006003222A9 true WO2006003222A9 (es) | 2009-01-15 |
Family
ID=35614437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/ES2005/000365 WO2006003222A1 (es) | 2004-06-29 | 2005-06-28 | Uso del formoterol en el tratamiento profiláctico y/o terapéutico del desgaste muscular y/o síndrome caquéctico, asociados a estados catabólicos de ciertas enfermedades como cáncer, sida, infecciones, diabetes y otras |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1818052B1 (es) |
AT (1) | ATE447944T1 (es) |
CY (1) | CY1109771T1 (es) |
DE (1) | DE602005017659D1 (es) |
DK (1) | DK1818052T3 (es) |
ES (2) | ES2245612B1 (es) |
PL (1) | PL1818052T3 (es) |
PT (1) | PT1818052E (es) |
WO (1) | WO2006003222A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0625270D0 (en) * | 2006-12-19 | 2007-01-31 | Univ Leicester | Angiogenesis |
CA2721739C (en) * | 2007-04-24 | 2016-08-23 | Acacia Pharma Limited | Drug combination and its use in the treatment of muscle loss |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9903995D0 (sv) * | 1999-11-03 | 1999-11-03 | Astra Ab | New combination |
GB9928311D0 (en) * | 1999-11-30 | 2000-01-26 | Novartis Ag | Organic compounds |
AU2002252950A1 (en) * | 2001-02-22 | 2002-09-04 | Universitatsklinikum Charite Medizinische Fakultat Der Humboldt-Universitat Zu Berlin | Protein kinase d inhibitors and protein kinase 2 inhibitors as agents for inhibiting tumour cells and for stimulating angiogenesis |
-
2004
- 2004-06-29 ES ES200401941A patent/ES2245612B1/es not_active Expired - Lifetime
-
2005
- 2005-06-28 DE DE602005017659T patent/DE602005017659D1/de active Active
- 2005-06-28 PT PT05763090T patent/PT1818052E/pt unknown
- 2005-06-28 WO PCT/ES2005/000365 patent/WO2006003222A1/es active Application Filing
- 2005-06-28 EP EP05763090A patent/EP1818052B1/en not_active Not-in-force
- 2005-06-28 AT AT05763090T patent/ATE447944T1/de active
- 2005-06-28 DK DK05763090.7T patent/DK1818052T3/da active
- 2005-06-28 PL PL05763090T patent/PL1818052T3/pl unknown
- 2005-06-28 ES ES05763090T patent/ES2336229T3/es active Active
-
2010
- 2010-02-10 CY CY20101100135T patent/CY1109771T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE602005017659D1 (de) | 2009-12-24 |
ATE447944T1 (de) | 2009-11-15 |
WO2006003222A1 (es) | 2006-01-12 |
EP1818052B1 (en) | 2009-11-11 |
DK1818052T3 (da) | 2010-03-29 |
CY1109771T1 (el) | 2014-09-10 |
ES2336229T3 (es) | 2010-04-09 |
PL1818052T3 (pl) | 2010-04-30 |
ES2245612A1 (es) | 2006-01-01 |
ES2245612B1 (es) | 2007-08-16 |
PT1818052E (pt) | 2010-02-15 |
EP1818052A1 (en) | 2007-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004072031A3 (en) | Phenylacetamides and their use as glucokinase modulators | |
WO2006017188A3 (en) | Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients | |
CY1105082T1 (el) | Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας | |
WO2004030611A3 (en) | Non-nucleoside reverse transcriptase inhibitors | |
WO2007062093A3 (en) | Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor | |
WO2008020027A3 (en) | 2,5-dihydroxybenzene compounds for the treatment of skin cancer | |
WO2006009874A3 (en) | Methods and compositions for treatment of excess nitric oxide or cyanide toxicity | |
DK2170857T3 (da) | 3',4',5-trimethoxyflavonderivater som stimulerende middel ved slimafsondring, tilsvarende fremgangsmåde og farmaceutisk præparat, der indeholder disse | |
WO2005082413A3 (en) | Ciclesonide and glycopyrronium combination | |
WO2007023072A3 (en) | Use of ambroxol for the treatment of rhinovirus infections | |
IL177169A (en) | Use of n-(2-aryl- propionyl)-sulfonamides for the preparation of medicaments for the treatment of spinal cord injury | |
WO2006003222A9 (es) | Uso del formoterol en el tratamiento profiláctico y/o terapéutico del desgaste muscular y/o síndrome caquéctico, asociados a estados catabólicos de ciertas enfermedades como cáncer, sida, infecciones, diabetes y otras | |
PT1670489E (pt) | Utilização de xénon com hipotermia para o tratamento de asfixia neonatal | |
WO2005055956A3 (en) | Method for improving insulin sensitivity by administering an inhibitor of antitrypsin | |
PT1220676E (pt) | Prevencao do cancro colorrectal | |
WO2004110373A3 (en) | Therapeutic vaccine compositions for the treatment of type 1 diabetes | |
HK1081862A1 (en) | Synergistic combination comprising roflumilast and (r,r)-formoterol | |
WO2005107871A3 (en) | Pyrroloquinoline quinone drugs for treatment of cardiac injury | |
WO2007117272A3 (en) | Methods for treatment of hemorrhagic shock and related disorders | |
DK1416937T3 (da) | Profylaktisk og terapeutisk anvendelse af hydroxysteroider | |
TW200512183A (en) | 2-alkylidene-19-nor-vitamin d derivatives for the treatment of frailty, muscle damage or sarcopenia | |
WO2002080889A3 (en) | A combination dosage of a cyclooxygenase (cox) inhibitor, a vitamin d3 including analogues and metabolites thereof and/or calcium for prevention of epithelial cancer | |
EP1589961A4 (en) | THERAPEUTIC COMPOSITION FOR THE TREATMENT OF HIV-1 AND HIV-2 VIRUSES | |
WO2006017921A8 (en) | Selective muscle relaxant and pharmaceutical compositions | |
EP1611895A8 (en) | Use of n-acetyl-d-aminoglycosamine in treatment of organ lesions related to toxicosis of drugs or chemicals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005763090 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2005763090 Country of ref document: EP |